Human/Mouse/Rat Phospho-ERK1 (T202/Y204) DuoSet IC ELISA

Catalog #: DYC1825-2
11 Citations Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
DYC1825E
DYC1825-5
DYC1825-2

Ancillary Products Available

5 Images

All ERK1 ELISAs

Product Details

Citations (11)

Supplemental Products

Reviews

Summary Product Features Kit Content Other Reagents Required Data Examples Product Datasheets Preparation and Storage Background

Human/Mouse/Rat Phospho-ERK1 (T202/Y204) DuoSet IC ELISA Summary

Assay Type

Solid Phase Sandwich ELISA

Format

96-well strip plate

Assay Length

4 hours 40 minutes (after plate preparation)

Sample Volume Required

Cell lysates (100 µL)

Assay Range

125.0 - 8,000 pg/mL

Sufficient Materials

Kits available for two, five, or fifteen 96-well plates*

Specificity

Please see the product datasheet

* Provided that the recommended microplates, buffers, diluents, substrates and solutions are used, and the assay is run as summarized in the Assay Procedure provided.

This DuoSet IC ELISA contains the basic components required for the development of sandwich ELISAs to measure phosphorylated human, mouse, and rat ERK1 (T202 / Y204) in cell lysates. An immobilized capture antibody specific for ERK1 binds both phosphorylated and unphosphorylated ERK1. After washing away unbound material, a biotinylated detection antibody is used to detect only phosphorylated receptor, utilizing a standard HRP format.

Product Features

Optimized capture and detection antibody pairings with recommended concentrations save lengthy development time
Development protocols are provided to guide further assay optimization
Assay can be customized to your specific needs
Available in 2, 5, and 15- (96-well) plate pack sizes
Economical alternative to Western blot

Kit Content

Capture Antibody
Conjugated Detection Antibody
Calibrated Immunoassay Standard or Control
Streptavidin-HRP

Other Reagents Required

PBS: (Catalog # DY006), or 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na₂HPO₄, 1.5 mM KH₂O₄, pH 7.2 - 7.4, 0.2 µm filtered

Wash Buffer: (Catalog # WA126), or equivalent

Lysis Buffer*

IC Diluent*

Blocking Buffer*

Substrate Solution: 1:1 mixture of Color Reagent A (H₂O₂) and Color Reagent B (Tetramethylbenzidine) (Catalog # DY999)

Stop Solution: 2 N H₂SO₄ (Catalog # DY994)

Microplates: From Costar EIA Plate (Costar Catalog # 2592) or R&D Systems (Catalog # DY990), or equivalent

Plate Sealers: ELISA Plate Sealers (Catalog # DY992), or equivalent

*For the Lysis Buffer, IC Diluent, and Blocking BUffer recommended for a specific DuoSet ELISA Development Kit, please see the product

Scientific Data

ELISA

View Larger

Standard Curve

N/A

View Larger

Specificity of Human/Mouse/Rat Phospho-ERK1 (T2002/Y204) DuoSet IC ELISA is Shown by Western Blot. Lysates prepared from HeLa human cervical epithelial carcinoma cells treated with 200 nM phorbol 12-myristate 13-acetate (PMA) were incubated in wells coated with Phospho-ERK1 Capture Antibody. Unbound material was removed by washing and bound material was solubilized in SDS gel sample buffer. The same lysate and captured proteins were electrophoresed, transferred to a PVDF membrane and immunoblotted with Phospho-ERK1 Detection Antibody. Only a single band corresponding to phosphorylated ERK1 was detected. While present in lysate at greater amounts than ERK1, phosphorylated ERK2 was not present in the captured material.

N/A

View Larger

Quantification of Phosphorylated ERK1 in PMA-treated Human HeLa Cells. HeLa human cervical epithelial carcinoma cells were treated with 200 nM PMA for the indicated times. Following cell lysis, ERK1 phosphorylated at T202/Y204 was quantified with this DuoSet IC ELISA. The same lysates were also immunoblotted (inset) with either Anti-phospho-ERK1/ERK2 (p-ERK1/ERK2) (Catalog # AF1575) or anti-ERK1 polyclonal antibodies. The DuoSet IC ELISA results correlate well with the relative amounts of phosphorylated ERK1 detected by Western blot (upper molecular weight band of upper blot corresponds to phosphorylated ERK1). The blot with anti-ERK1 antibody indicates that total levels of ERK1 remained constant during incubations with PMA.The quantification of phosphorylated ERK1 with this DuoSet IC ELISA was also determined in cells pretreated with the MEK1/2 inhibitors U0126 and PD98059, which indirectly inhibit phosphorylation of ERK1 at T202/Y204.

N/A

View Larger

Quantification of Phosphorylated ERK1 in U0126- and PD98059-treated Human HeLa Cells. HeLa human cervical epithelial carcinoma cells were untreated or treated with 200 nM PMA for 20 minutes, either with or without 50 mM U0126 or 50 mM PD98059. Cells were lysed and ERK1 phosphorylated at T202/Y204 was quantified with this DuoSet IC ELISA. The same lysates were also immunoblotted (inset) with either anti-phospho- ERK1/ERK2 (p-ERK1/ERK2) or anti-ERK1 polyclonal antibodies. The DuoSet IC ELISA results correlate well with the total amounts of phosphorylated ERK1 detected by Western blot. The blot with anti-ERK1 antibody indicates that total levels of ERK1 remained constant during the various treatments.This DuoSet IC ELISA also quantifies phosphorylated ERK1 levels in mouse and rat cell lysates.

N/A

View Larger

Quantification of Phosphorylated ERL1 in Growth Factor-treated Mouse and Rat Cells. Lysates prepared from NIH/3T3 mouse embryonic fibroblast cells either uninduced or induced with 100 ng/mL PDGF (Catalog # 120-HD) (left panel), and PC-12 rat adrenal pheochromocytoma cells either uninduced or induced with 100 ng/mL beta-NGF (Catalog # 556-NG) (right panel) were quantified with this DuoSet IC ELISA. The same lysates were also immunoblotted (inset) with either anti-phospho-ERK1/ERK2 (p-ERK1/ERK2) or anti-ERK1 polyclonal antibodies. The DuoSet IC ELISA results correlate well with the total amounts of phosphorylated ERK1 detected by Western blot. The blots with anti-ERK1 antibody indicate that total levels of ERK1 remained constant during the growth factor inductions.

Product Datasheets

Product Datasheet

COA

SDS

Preparation and Storage

Shipping

The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Background: ERK1

ERK1 and ERK2 (also known as MAPK3 and MAPK1) are 44 and 42 kDa Ser/Thr kinases, respectively. They are part of the Ras-Raf-ERK signal transduction cascade often found downstream of growth factor receptor activation. ERK1 and ERK2 were initially isolated and cloned as kinases activated in response to insulin and NGF. They are expressed in most, if not all, mammalian tissues. Dual threonine and tyrosine phosphorylation activate both ERKs, at Thr202/Tyr204 for human ERK1 and Thr185/Tyr187 for human ERK2.

ERK5, also known as Big Mitogen-activated Protein Kinase 1 (BMK1) and MAPK7, is activated by several mechanisms, including receptor tyrosine kinases, G protein-coupled receptors, and osmotic stress. Like ERK1 and ERK2, ERK5 contains the conserved Thr-Glu-Tyr activation motif in its activation loop. Unlike these ERKs, however, ERK5 contains a unique C-terminal domain that regulates its activation and nuclear translocation.

Long Name:

Extracellular Signal-regulated Kinase 1

Entrez Gene IDs:

5595 (Human); 26417 (Mouse); 50689 (Rat)

Alternate Names:

EC 2.7.11; ERK1; ERK-1; ERK1p44-MAPK; ERT2; Extracellular signal-regulated kinase 1; extracellular signal-related kinase 1; HS44KDAP; HUMKER1A; Insulin-stimulated MAP2 kinase; MAP kinase 1; MAP kinase 3; MAP kinase isoform p44; MAPK 1; MAPK 3; MAPK3; MGC20180; Microtubule-associated protein 2 kinase; Mitogen-activated protein kinase 1; mitogen-activated protein kinase 3; P44ERK1; p44-ERK1; p44mapk; PRKM3; PRKM3EC 2.7.11.24

Citations for Human/Mouse/Rat Phospho-ERK1 (T202/Y204) DuoSet IC ELISA

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

11 Citations: Showing 1 - 10
Filter your results:

Filter by:

Prophylactic Evidence of MSCs-Derived Exosomes in Doxorubicin/Trastuzumab-Induced Cardiotoxicity: Beyond Mechanistic Target of NRG-1/Erb Signaling Pathway
Authors: N Ebrahim, HA Al Saihati, O Mostafa, A Hassouna, S Abdulsamea, E Abd El Azi, NH Abo-Rayah, D Sabry, M El-Sherbin, AG Madboly, NI Hussien, REH Saadani, HA Ebrahim, OAM Badr, NM Elsherbiny, RF Salim
International Journal of Molecular Sciences, 2022-05-25;23(11):.
Species: Rat
Sample Types: Tissue Homogenates
Stand-Sit Microchip for High-Throughput, Multiplexed Analysis of Single Cancer Cells
Sci Rep, 2016-09-01;6(0):32505.
Applications: ChIP
The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)/phosphorylated ERK/DNMT1 protein pathway in T-cells from controls and systemic lupus erythematosus patients.
Authors: Sunahori, Katsue, Nagpal, Kamalpre, Hedrich, Christia, Mizui, Masayuki, Fitzgerald, Lisa M, Tsokos, George C
J Biol Chem, 2013-06-17;288(30):21936-44.
Species: Human
Sample Types: Cell Lysates
Global quantitative phosphoproteome analysis of human tumor xenografts treated with a CD44 antagonist.
Authors: Weigand S, Herting F, Maisel D, Nopora A, Voss E, Schaab C, Klammer M, Tebbe A
Cancer Res, 2012-07-09;72(17):4329-39.
Species: Mouse
Sample Types: Tissue Homogenates
Real-time monitoring of Cisplatin-induced cell death.
Authors: Alborzinia H, Can S, Holenya P, Scholl C, Lederer E, Kitanovic I, Wolfl S
PLoS ONE, 2011-05-16;6(5):e19714.
Species: Human
Sample Types: Cell Lysates
Microarray-based kinetic colorimetric detection for quantitative multiplex protein phosphorylation analysis.
Authors: Holenya P, Kitanovic I, Heigwer F, Wolfl S
Proteomics, 2011-04-18;11(10):2129-33.
Species: Human
Sample Types: Recombinant Protein
Protein secretion in human mammary epithelial cells following HER1 receptor activation: influence of HER2 and HER3 expression.
Authors: Zhang Y, Gonzalez RM, Zangar RC
BMC Cancer, 2011-02-14;11(0):69.
Species: Human
Sample Types: Cell Lysates
Lipopolysaccharide-activated IL-10-secreting dendritic cells suppress experimental autoimmune uveoretinitis by MHCII-dependent activation of CD62L-expressing regulatory T cells.
Authors: Lau AW, Biester S, Cornall RJ, Forrester JV
J. Immunol., 2008-03-15;180(6):3889-99.
Species: Mouse
Sample Types: Cell Lysates
Preclinical pharmacokinetic/pharmacodynamic models of gefitinib and the design of equivalent dosing regimens in EGFR wild-type and mutant tumor models.
Authors: Wang S, Guo P, Wang X, Zhou Q, Gallo JM
Mol. Cancer Ther., 2008-02-01;7(2):407-17.
Species: Mouse
Sample Types: Tissue Homogenates
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance.
Authors: Aguila B, Coulbault L, Boulouard M, Leveille F, Davis A, Toth G, Borsodi A, Balboni G, Salvadori S, Jauzac P, Allouche S
Br. J. Pharmacol., 2007-11-05;152(8):1312-24.
Species: Human
Sample Types: Cell Lysates

Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration.
Authors: Proost P, Mortier A, Loos T, Vandercappellen J, Gouwy M, Ronsse I, Schutyser E, Put W, Parmentier M, Struyf S, Van Damme J
Blood, 2007-03-15;110(1):37-44.
Species: Hamster
Sample Types: Cell Lysates